AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27097042 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-Protein (CHO-P; 0.8 g carbohydrate·kg body mass [BM-1]·h-1 plus 0.4 g protein·kg BM-1·h-1)
Number of subjects: 6
Study 27097042 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric Carbohydrate (CHO; 1.2 g carbohydrate·kg BM-1·h-1)
Number of subjects: 6
Study 23553613 — intervention group
Group type: EXPERIMENTAL
Intervention: Office evaluation plus urodynamic testing (OE + UDS)
Number of subjects: 630
Study 23553613 — intervention group
Group type: COMPARATOR
Intervention: Office evaluation (OE)
Number of subjects: 630
Study 22387271 — intervention group
Group type: EXPERIMENTAL
Intervention: HUT + LBNP with added mental challenge (2 min before expected presyncope time)
Number of subjects: 5
Study 22387271 — intervention group
Group type: COMPARATOR
Intervention: HUT + LBNP (control)
Number of subjects: 5
Study 20636196 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) group
Number of subjects: 58
Study 20636196 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 58
Study 18702350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg pegaptanib sodium
Number of subjects: 95
Study 18702350 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg pegaptanib sodium
Number of subjects: 95
Study 15935650 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 80
Study 15935650 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine plus fentanyl 100 microg
Number of subjects: 80
Study 12511360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% gel (1 ml)
Number of subjects: 107
Study 12511360 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 4% unpreserved eyedrops (0.5 ml)
Number of subjects: 107
Study 10190222 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine therapy
Number of subjects: 1996
Study 10190222 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol therapy
Number of subjects: 1996
Study 8926734 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive inhalation of 100 and 200 mg freebase cocaine
Number of subjects: 6
Study 8926734 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 1 mg cocaine hydrochloride
Number of subjects: 6
Study 8926734 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exposure to sidestream smoke from crack smokers
Number of subjects: 6
Study 2257862 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal of low-dose prednisolone (0.3-0.6 mg/kg body weight)
Number of subjects: 10
Study 215304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathoracic Bacillus Calmette-Guérin (BCG)
Number of subjects: 100
Study 215304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathoracic Bacillus Calmette-Guérin (BCG) plus levamisole
Number of subjects: 100
Study 215304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 215304 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified protein derivative conversion
Number of subjects: 100
Study 30713154 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive term-time workers (> 12 h/w and in regular work)
Number of subjects: 2800
Study 30713154 — intervention group
Group type: COMPARATOR
Intervention: Non-workers
Number of subjects: 2800
Study 30713154 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate workers (≤ 12 h/w and/or in irregular work)
Number of subjects: 2800
Study 30713154 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors
Number of subjects: 2800
Study 30713154 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 2800
Study 28249624 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion-focused therapy (CFT)
Number of subjects: 50
Study 28249624 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 50
Study 28249624 — intervention group
Group type: EXPERIMENTAL
Intervention: CFT
Number of subjects: 50
Study 28249624 — intervention group
Group type: COMPARATOR
Intervention: CBT
Number of subjects: 50
Study 25966065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of umbilical cord MSCs along with medication
Number of subjects: 59
Study 25966065 — intervention group
Group type: COMPARATOR
Intervention: Medication only (control group)
Number of subjects: 59
Study 23234753 — intervention group
Group type: EXPERIMENTAL
Intervention: RBANS Effort Index (EI)
Number of subjects: 128
Study 23234753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutoff score of >4 for EI
Number of subjects: 128
Study 23234753 — intervention group
Group type: COMPARATOR
Intervention: Overall cognitive functioning and symptoms of psychopathology
Number of subjects: 128
Study 20306091 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training
Number of subjects: 16
Study 20306091 — intervention group
Group type: COMPARATOR
Intervention: Apprenticeship training
Number of subjects: 16
Study 19228659 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) treatment
Number of subjects: 0
Study 19228659 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment
Number of subjects: 0
Study 19228659 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination ETN and MTX treatment
Number of subjects: 0
Study 19228659 — intervention group
Group type: COMPARATOR
Intervention: Control group (severe RA)
Number of subjects: 0
Study 16820633 — intervention group
Group type: EXPERIMENTAL
Intervention: Prima Plus stentless bioprosthesis
Number of subjects: 161
Study 16820633 — intervention group
Group type: COMPARATOR
Intervention: C‐E Perimount stented bioprosthesis
Number of subjects: 161
Study 12725261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 40
Study 12725261 — intervention group
Group type: COMPARATOR
Intervention: Oral iron
Number of subjects: 40
Study 10673065 — intervention group
Group type: EXPERIMENTAL
Intervention: Niravoline (0.5 to 2 mg iv)
Number of subjects: 18
Study 10673065 — intervention group
Group type: EXPERIMENTAL
Intervention: Niravoline (1.5 mg or 2 mg iv)
Number of subjects: 18
Study 9326749 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (KTCZ)
Number of subjects: 27
Study 9326749 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT1A agonist ipsapirone (IPS)
Number of subjects: 27
Study 9326749 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 27
Study 8452380 — intervention group
Group type: EXPERIMENTAL
Intervention: SDI test with adjuvant chemotherapy using tegafur and one of the following drugs: mitomycin C (MMC), adriamycin (ADM), or cisplatin (CDDP).
Number of subjects: 0
Study 3526915 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG feedback
Number of subjects: 12
Study 3526915 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy procedure (NDT)
Number of subjects: 12
Study 27168018 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar TURP
Number of subjects: 186
Study 27168018 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 186
Study 27168018 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective Vaporization of the Prostate (PVP)
Number of subjects: 186
Study 27168018 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 186
Study 26926307 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical Intravelar Veloplasty (RIVVP)
Number of subjects: 20
Study 26926307 — intervention group
Group type: EXPERIMENTAL
Intervention: V‐Y Pushback Pharyngoplasty and Radical Intravelar Veloplasty (VYP+RIVVP)
Number of subjects: 20
Study 26926307 — intervention group
Group type: COMPARATOR
Intervention: RIVVP and VYP+RIVVP
Number of subjects: 20
Study 26926307 — intervention group
Group type: COMPARATOR
Intervention: Palatal lengthening
Number of subjects: 20
Study 23954938 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (standard)
Number of subjects: 255
Study 23954938 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (relapse prevention)
Number of subjects: 255
Study 23954938 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 255
Study 22830462 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CCTA
Number of subjects: 1000
Study 22830462 — intervention group
Group type: COMPARATOR
Intervention: Standard evaluation
Number of subjects: 1000
Study 22830462 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 1000
Study 20687924 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk communication on cardiovascular disease (CVD) on top of standard managed care, including a simple explanation of causes, consequences, and prevention of CVD, with probabilities explained in natural frequencies and visualized by a population diagram.
Number of subjects: 240
Study 20687924 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk communication on cardiovascular disease (CVD) on top of standard managed care.
Number of subjects: 240
Study 20687924 — intervention group
Group type: COMPARATOR
Intervention: Standard managed care.
Number of subjects: 240
Study 18034788 — intervention group
Group type: EXPERIMENTAL
Intervention: SSP+ (platelet additive solution with potassium and magnesium)
Number of subjects: 10
Study 18034788 — intervention group
Group type: COMPARATOR
Intervention: Intersol (control platelet additive solution)
Number of subjects: 10
Study 16899628 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg daily
Number of subjects: 213
Study 16899628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 12418614 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity night-time therapeutic electrical stimulation (TES) applied to the deltoid and biceps muscle from 6 to 12 months.
Number of subjects: 13
Study 12418614 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulator applied to the opposite arm as control.
Number of subjects: 13
Study 10512132 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral etoposide, 50 mg/m2, days 1‐21
Number of subjects: 171
Study 10512132 — intervention group
Group type: COMPARATOR
Intervention: Intravenous etoposide, 200 mg/m2, days 1‐3
Number of subjects: 171
Study 7491386 — intervention group
Group type: EXPERIMENTAL
Intervention: neuroleptics
Number of subjects: 12
Study 7491386 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 2037844 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine doses (four different doses administered)
Number of subjects: 0
Study 2037844 — intervention group
Group type: COMPARATOR
Intervention: Expectancy instructional set
Number of subjects: 0
Study 6282192 — intervention group
Group type: EXPERIMENTAL
Intervention: Azlocillin plus Amikacin
Number of subjects: 40
Study 6282192 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime plus Amikacin
Number of subjects: 40
Study 6282192 — intervention group
Group type: EXPERIMENTAL
Intervention: Azlocillin plus Cefotaxime
Number of subjects: 40
Study 30645635 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 10mg/day for 1 year
Number of subjects: 2291
Study 30879462 — intervention group
Group type: EXPERIMENTAL
Intervention: K-wire fixation (n=72)
Number of subjects: 102
Study 30879462 — intervention group
Group type: COMPARATOR
Intervention: Palmar plate fixation (n=30)
Number of subjects: 102
Study 26792349 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete mesocolic excision (CME), n=39
Number of subjects: 85
Study 24210997 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined turning gait
Number of subjects: 5
Study 24210997 — intervention group
Group type: COMPARATOR
Intervention: Imagined gait tasks (simple and complex)
Number of subjects: 5
Study 24210997 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking speed correlation
Number of subjects: 5
Study 24210997 — intervention group
Group type: EXPERIMENTAL
Intervention: Altered SMA activity during imagined turning
Number of subjects: 5
Study 24210997 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowered activity in GP
Number of subjects: 5
Study 23446658 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL) treatment
Number of subjects: 316
Study 23446658 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 316
Study 20089780 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain rye bread (minimum 240 g/d)
Number of subjects: 51
Study 17947289 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint attention intervention
Number of subjects: 35
Study 17947289 — intervention group
Group type: COMPARATOR
Intervention: Symbolic play intervention
Number of subjects: 35
Study 15629602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MC) 15 mg/M(2)
Number of subjects: 128
Study 15629602 — intervention group
Group type: COMPARATOR
Intervention: Porfiromycin (POR) 40 mg/M(2)
Number of subjects: 128
Study 12183719 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation program (15 minutes of stimulation of oral structures, once per day for 10 days)
Number of subjects: 32
Study 12183719 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation program
Number of subjects: 32
Study 12183719 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation program (control)
Number of subjects: 32
Study 9891914 — intervention group
Group type: EXPERIMENTAL
Intervention: Living near cement kilns (Midlothian, Texas)
Number of subjects: 58
Study 7845271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 52
Study 7845271 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide with dexamethasone
Number of subjects: 52
Study 3041924 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-8980
Number of subjects: 145
Study 3041924 — intervention group
Group type: COMPARATOR
Intervention: Auranofin
Number of subjects: 145
Study 29793053 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with sodium (0.8 g/d) and fluid (800 mL/d) restriction
Number of subjects: 53
Study 29793053 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted diet
Number of subjects: 53
Study 27003301 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg of Lupron
Number of subjects: 38
Study 27003301 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg of Lupron and estrogen replacement
Number of subjects: 38
Study 27003301 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 38
Study 27003301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupron
Number of subjects: 38
Study 27003301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupron and estrogen replacement
Number of subjects: 38
Study 25106008 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerated Bone 12 months post-extraction (RB12)
Number of subjects: 216
Study 25106008 — intervention group
Group type: COMPARATOR
Intervention: Healed Bone (HB)
Number of subjects: 216
Study 25106008 — intervention group
Group type: COMPARATOR
Intervention: Regenerated Bone 6 months post-extraction (RB6)
Number of subjects: 216
Study 22749295 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Oswestry Disability Index
Number of subjects: 55
Study 22749295 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Swiss Spinal Stenosis Scale (SSS)
Number of subjects: 55
Study 22749295 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Specific Functional Scale
Number of subjects: 55
Study 22749295 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeric Pain Rating Scale (NPRS)
Number of subjects: 55
Study 20543733 — intervention group
Group type: EXPERIMENTAL
Intervention: Full range of motion (FRoM) testing
Number of subjects: 23
Study 20543733 — intervention group
Group type: EXPERIMENTAL
Intervention: Short range of motion (SRoM1) testing
Number of subjects: 23
Study 20543733 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral comparison (involved vs. uninvolved hand)
Number of subjects: 23
Study 20543733 — intervention group
Group type: EXPERIMENTAL
Intervention: FRoM and SRoM1 isokinetic testing
Number of subjects: 23
Study 20543733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic weakness of the wrist extension-flexion apparatus
Number of subjects: 23
Study 19011166 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated archwires (as-received)
Number of subjects: 10
Study 19011166 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieved coated archwires (after 4-6 weeks of use)
Number of subjects: 10
Study 19011166 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieved coated archwires
Number of subjects: 10
Study 15927936 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk (375 microg folic acid)
Number of subjects: 73
Study 15927936 — intervention group
Group type: COMPARATOR
Intervention: Control milk (unfortified)
Number of subjects: 73
Study 15347862 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow breathing exercise for three months
Number of subjects: 60
Study 15347862 — intervention group
Group type: COMPARATOR
Intervention: Fast breathing exercise for three months
Number of subjects: 60
Study 10995594 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion at 100 mg/kg for 30 min
Number of subjects: 20
Study 10995594 — intervention group
Group type: COMPARATOR
Intervention: D-arginine infusion at 100 mg/kg for 30 min
Number of subjects: 20
Study 10995594 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion at 500 mg/kg for 30 min
Number of subjects: 20
Study 10995594 — intervention group
Group type: COMPARATOR
Intervention: D-arginine infusion at 500 mg/kg for 30 min
Number of subjects: 20
Study 10995594 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion
Number of subjects: 20
Study 10995594 — intervention group
Group type: COMPARATOR
Intervention: D-arginine infusion
Number of subjects: 20
Study 9315539 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (0.2 to 0.3 mg x kg[-1] x d[-1], maximum 15 mg) for 10 weeks
Number of subjects: 18
Study 9315539 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 10 weeks
Number of subjects: 18
Study 8299529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd: YAG pulsed laser intervention for desensitization
Number of subjects: 0
Study 3511311 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pump therapy (N = 11)
Number of subjects: 22
Study 3511311 — intervention group
Group type: COMPARATOR
Intervention: Intensive conventional insulin therapy (N = 11)
Number of subjects: 22
Study 2500784 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist visits (11 physicians)
Number of subjects: 31
Study 2500784 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-comparison feedback (10 physicians)
Number of subjects: 31
Study 2500784 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 physicians)
Number of subjects: 31
Study 30728034 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIRIT intervention (1-year programme including audit, feedback, goal setting, leadership programme, staff training, systems testing, researcher exchange)
Number of subjects: 6
Study 30728034 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIRIT intervention (1-year programme)
Number of subjects: 6
Study 27709308 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser acupuncture (12 sessions, 3 sessions/week)
Number of subjects: 48
Study 27709308 — intervention group
Group type: COMPARATOR
Intervention: Sham laser acupuncture (12 sessions, 3 sessions/week)
Number of subjects: 48
Study 27709308 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser acupuncture
Number of subjects: 48
Study 26069231 — intervention group
Group type: EXPERIMENTAL
Intervention: Elosulfase alfa 2.0mg/kg/week
Number of subjects: 25
Study 26069231 — intervention group
Group type: EXPERIMENTAL
Intervention: Elosulfase alfa 4.0mg/kg/week
Number of subjects: 25
Study 26069231 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 25
Study 24067320 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulated light projections (specific colors and modulations in the frequency range of brainwaves)
Number of subjects: 117
Study 24067320 — intervention group
Group type: COMPARATOR
Intervention: Placebo projection (nonmodulated white light)
Number of subjects: 117
Study 21829202 — intervention group
Group type: EXPERIMENTAL
Intervention: GP's endorsement letter
Number of subjects: 1288
Study 21829202 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced procedural leaflet
Number of subjects: 1288
Study 21829202 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GP's letter and leaflet
Number of subjects: 1288
Study 21829202 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic GP's signature on endorsement letter
Number of subjects: 1288
Study 18180980 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment (10.6 microm and 650 nm laser irradiation)
Number of subjects: 40
Study 18180980 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser treatment (sham laser treatment)
Number of subjects: 40
Study 17122208 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. amino acid infusion (4 kJ kg(‐1) h(‐1) starting 2 h before surgery)
Number of subjects: 180
Study 17122208 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. amino acid infusion
Number of subjects: 180
Study 17122208 — intervention group
Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 180
Study 15068108 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane (COLL)
Number of subjects: 20
Study 15068108 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane + Demineralized freeze-dried bone allograft (COBA)
Number of subjects: 20
Study 11332875 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimantadine hydrochloride (100 mg) - Test formulation (Rimantadin Lachema)
Number of subjects: 24
Study 9153484 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole therapy for 1 week (n = 25)
Number of subjects: 50
Study 9153484 — intervention group
Group type: COMPARATOR
Intervention: Albendazole therapy for 2 weeks (n = 25)
Number of subjects: 50
Study 7968650 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (oral or transdermal)
Number of subjects: 61
Study 7968650 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (transdermal)
Number of subjects: 61
Study 7968650 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (oral)
Number of subjects: 61
Study 7968650 — intervention group
Group type: COMPARATOR
Intervention: Reference group (untreated)
Number of subjects: 61